Eli Lilly & Co

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Eli Lilly & Co
CIK #0000059478
EDGAR Form CIK 2011 - 2026
10-K [0000059478]
10-Q [0000059478]
3 [0000059478]
4 [0000059478]
5 [0000059478]
8-K [0000059478]
SC 13D [0000059478]
SC 13G [0000059478]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Capital Management LLC Eli Lilly & Co [2026-05-01]
Eli Lilly & Co Aktis Oncology Inc [2026-01-15]
Eli Lilly & Co Sigilon Therapeutics Inc [2023-07-07]
Eli Lilly & Co Akouos Inc [2022-10-27]
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10]
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13]
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10]
Eli Lilly & Co AC Immune Sa [2021-02-12]
Eli Lilly & Co Sigilon Therapeutics Inc [2021-02-12]
Eli Lilly & Co Avidity Biosciences Inc [2021-02-12]
Eli Lilly & Co Precision Biosciences Inc [2021-01-08]
Eli Lilly & Co Prevail Therapeutics Inc [2020-12-22]
PNC Financial Services Group Inc Eli Lilly & Co [2020-02-14]
Eli Lilly & Co Dermira Inc [2020-01-10]
Lilly Eli & Co Elanco Animal Health Inc [2019-02-14]
Lilly Eli & Co Loxo Oncology Inc [2019-01-15]
Lilly Eli & Co Dicerna Pharmaceuticals Inc [2018-12-20]
Lilly Eli & Co Zymeworks Inc [2018-02-14]
Lilly Eli & Co Leap Therapeutics Inc [2017-11-22]
Wellington Management Group LLP Lilly Eli & Co [2017-02-09]
Lilly Eli & Co Colucid Pharmaceuticals Inc [2017-01-27]
Lilly Eli & Co Lilly Eli & Co [2016-04-22]
Vanguard Group Inc Lilly Eli & Co [2016-02-11]
Lilly Eli & Co Ignyta Inc [2015-11-16]
Lilly Eli & Co Cerulean Pharma Inc [2015-02-17]
Lilly Eli & Co Zosano Pharma Corp [2015-02-09]
Lilly Eli & Co Coherus Biosciences Inc [2014-11-24]
PRIMECAP Management Co/CA/ Lilly Eli & Co [2014-03-07]
Wellington Management Co LLP Lilly Eli & Co [2014-02-14]
Form 3/4/5 Subject 2011 - 2026
Eli Lilly & Co
Fyrwald J Erik
Alvarez Ralph
Sulzberger Gabrielle
Luciano Juan R
Yuffa Ilya
Lilly Endowment Inc
Dozier Eric
Zakrowski Donald A
Custer Kenneth L
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 5.01 $989.12 4,955
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 12.55 $989.12 12,413
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 10.03 $989.12 9,921
Eli Lilly & Co LLY
Common Stock
2026-03-16 Grant 16.09 $989.12 15,915
Eli Lilly & Co LLY
Common Stock
2026-02-19 Gift 481 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 11.99 $1,036.05 12,422
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 15.36 $1,036.05 15,914
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 9.57 $1,036.05 9,915
Eli Lilly & Co LLY
Common Stock
2026-02-17 Grant 4.79 $1,036.05 4,963
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 391 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 207 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 169.97 $1,040.00 176,769
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 159.73 $1,040.00 166,119
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 368 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 368 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Tax withheld 81.55 $1,040.00 84,812
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 184 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 184 $0.00
Eli Lilly & Co LLY
Restricted Stock Unit · derivative
2026-02-16 Option exercise 391 $0.00
Eli Lilly & Co LLY
Common Stock
2026-02-16 Option exercise 207 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com